Skip to main content
. 2023 Oct 31;4(2):100421. doi: 10.1016/j.xops.2023.100421

Figure 8.

Figure 8

Adjusted analysis of the association of change in visual acuity (VA) from baseline (BL) to year 1 with BL clinical and demographic characteristics for eyes included in the VA cohort.baContinuous variables. bGeneralized linear model adjusted for sex, race (White, Black, Asian, Hispanic, and other), payer type (Medicare, commercial, Medicaid, and other/unknown), provider subspecialty (retina specialist, general ophthalmologist, nonretina specialist, and other/unknown), BL VA, and comorbidities. Variables assessed included age (continuous), sex, race (White, Black, Asian, Hispanic, other coefficient [95% confidence interval {CI}] 0.03 [–0.98, 1.04], P = 0.95, and unknown coefficient [95% CI] –0.25 [–0.60, 0.10], P = 0.16), payer type (Medicare, commercial, Medicaid, and other/unknown coefficient [95% CI] –0.26 [–0.62, 0.09], P = 0.15), subspecialty (retina specialist, general ophthalmologist, nonretina specialist, and other/unknown coefficient [95% CI] –0.37 [–0.68, –0.05], P = 0.02), intravitreal anti-VEGF injections/anti-VEGF-1 injections through year 1, BL VA, and historical comorbidities (glaucoma and cataract). Ref = reference.